In the Past 30 Days...
PER WEEK
PER POST
PER POST
In the last 30 days, the average company in this landscape has grown their audience by <0.1%. Biologics by McKesson grew faster than everyone else, with 0.5% growth! On average, each post in this landscape earns more than 82.2 engagements. Abbott is topping the charts with more than 272.1 engagements per post on their 8 posts in the last 30 days.
1.32k Likes • 44 Comments
We couldn’t pick just one! What are your essentials for living fully?
174 Likes • 11 Comments
What's your ideal combo? #thisand
120 Likes • 0 Comments
The puzzle pieces are starting to fall into place for more efficient and effective Alzheimer's diagnosis. 🧩 Innovative blood-based biomarker tests, now being developed, are giving clinicians the tools they need to reliably diagnose Alzheimer's Disease (AD). This advancement means hopeful changes are ahead for early intervention and improved patient outcomes. Access the full article to learn …
106 Likes • 2 Comments
“Playing the piano with other instrumentalists or singers is one of my favorite things in the world. When playing music with others, there is often a magical moment when you instinctively understand how to interpret a piece without needing to speak.” Fiorenza, Global Program Safety Team Lead
62 Likes • 1 Comments
How can digital solutions be fit for purpose for healthcare professionals, while compatible with local infrastructures and care practices? In the latest episode of Cardio Insights hosted by Mathieu Chaffard, Sara Zimbardo shares her expertise in developing digital solutions that integrate seamlessly into diverse clinical workflows and infrastructures. Drawing from her work as Senior User Experience Designer …
87 Reactions • 24 Comments • 7 Shares
Save on Easter with buy 1, get 1 for $1 on select candy at CVS®.
43 Reactions • 5 Comments • 2 Shares
Check out this week's Extra Big Deals! Use your ExtraCare® card to get these deals April 13 to April 19, online and in store. https://cvs.co/4jrtl2E
28 Reactions • 6 Comments • 2 Shares
Spring is beautiful, but pollen allergies can be a real challenge! 🤧 Check out some tips in our article:
31 Reactions • 0 Comments • 3 Shares
“Playing the piano with other instrumentalists or singers is one of my favorite things in the world. When playing music with others, there is often a magical moment when you instinctively understand how to interpret a piece without needing to speak.” Fiorenza, Global Program Safety Team Lead
25 Reactions • 0 Comments • 5 Shares
Liver cancer incidence has tripled in the US over the past four decades, emphasizing the need for additional treatment approaches. Now, the U.S. Food and Drug Administration has approved our dual immunotherapy as a first-line option, which may offer hope for certain patients with a type of liver cancer called hepatocellular carcinoma. https://bit.ly/42ofOlm
18 Likes • 10 Retweets
Despite strides made in #oncology, the rise of counterfeit drugs poses an increasingly urgent challenge around the globe. Pfizer spoke to @OncLive to share our mission to combat counterfeit drugs and educate #oncologists on how to protect patients. on.pfizer.com/3Yngrue pic.x.com/JPXKh8whu4
23 Likes • 10 Retweets
MEDIA: @US_FDA approves first-line dual immunotherapy treatment option for certain patients with hepatocellular carcinoma. bit.ly/3Ed4Yqp pic.x.com/5Q2CdYeuE7
15 Likes • 1 Retweets
At #BHPS2025, we joined health leaders and advocates to discuss the future of HIV prevention and to drive meaningful action. By working with the communities most affected, we aim to ensure everyone receives the care and services they need to help end the #HIV epidemic. pic.x.com/Mabi22RVAw
5 Likes • 2 Retweets
Join our Q1 2025 #earnings call and webcast now: social.jnj.com/4cuf3vO $JNJ pic.x.com/u8pJ7rn7aO
11 Likes • 2 Retweets
At Gilead, we set and achieve bold ambitions in our fight against the world’s most devastating diseases. See Phan, Vice President, Oncology Clinical Development, discusses how Gilead is working to deliver innovative therapies that offer new hope for patients. pic.x.com/aHIgPLW2Qd
The Social Media Benchmark Report
Ready to see how you stack up to your industry’s top social performers? Review the latest metrics on channels, engagement, post types, and more.